Orthopaedics firm DePuy has voluntarily recalled two of its hip replacement products, after post-market surveillance data showed a high risk of revision rates for patients implanted with the devices1. The company said it had notified the US Food and Drug Administration and other regulatory agencies globally of the recall...
Please login to read the full article.
